SMURF1-mediated ubiquitination of ARHGAP26 promotes ovarian cancer cell invasion and migration

Nakata, S., Phillips, E. & Goidts, V. Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells. Cancer Manag. Res. 6, 171–180 (2014).

Paik, D. Y. et al. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells 30, 2487–2497 (2012).

Vargas, A. N. Natural history of ovarian cancer. Ecancermedicalscience 8, 465 (2014).

Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).

Hasebe, T., Fujimoto, K., Kajita, M. & Ishizuya-Oka, A. Thyroid hormone activates Wnt/beta-catenin signaling involved in adult epithelial development during intestinal remodeling in Xenopus laevis. Cell Tissue Res. 365, 309–318 (2016).

Ohta, K. et al. Graf1 controls the growth of human parainfluenza virus type 2 through inactivation of RhoA signaling. J. Virol. 90, 9394–9405 (2016).

Chen, X. et al. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. J. Exp. Clin. Cancer Res. 37, 128 (2018).

Brauer, P. R. et al. Kruppel-like factor 4 mediates cellular migration and invasion by altering RhoA activity. Cell. Commun. Adhes. 24, 1–10 (2018).

Aly, R. M. & Ghazy, H. F. High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia. Blood Cells Mol. Dis. 53, 185–158 (2014).

Borkhardt, A. et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc. Natl Acad. Sci. USA 97, 9168–9173 (2000).

Zohrabian, V. M. et al. Gene expression profiling of metastatic brain cancer. Oncol. Rep. 18, 321–328 (2007).

Luo, N. et al. ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells. Cell Death Dis. 7, e2157 (2016).

Finley, D. & Chau, V. Ubiquitination. Annu. Rev. Cell. Biol. 7, 25–69 (1991).

Fuchs, S. Y. Ubiquitination-mediated regulation of interferon responses. Growth Factors 30, 141–148 (2012).

Wang, W. et al. MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1. Biochem. Biophys. Res. Commun. 449, 432–437 (2014).

Lee, M. G. et al. RASSF1A directly antagonizes RhoA activity through the assembly of a Smurf1-mediated destruction complex to suppress tumorigenesis. Cancer Res. 76, 1847–1859 (2016).

Zhang, Y. et al. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. J. Exp. Clin. Cancer Res. 37, 116 (2018).

Luo, D. W. et al. UPP mediated diabetic retinopathy via ROS/PARP and NF-kappaB inflammatory factor pathways. Curr. Mol. Med. 15, 790–799 (2015).

Dahiya, N., Sherman-Baust, C. A., Wang, T. L. & Davidson, B. & Shih le, M. & Zhang, Y. et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3, e2436 (2008).

Lu, X., Wang, J., Shan, X. & Li, Y. Selecting key genes associated with ovarian cancer based on differential expression network. J. BUON. 22, 48–57 (2017).

Chen, Y. et al. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells. Br. J. Cancer 117, 1192–1201 (2017).

Zhao, R. et al. DDB2 modulates TGF-beta signal transduction in human ovarian cancer cells by downregulating NEDD4L. Nucleic Acids Res. 43, 7838–7849 (2015).

Langstraat, C., Aletti, G. D. & Cliby, W. A. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol. Oncol. 123, 187–191 (2011).

Yao, F. et al. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 12, 272–285 (2015).

Holst, M. R. et al. Clathrin-independent endocytosis suppresses cancer cell blebbing and invasion. Cell Rep. 20, 1893–1905 (2017).

Bommareddy, A. et al. Alpha-santalol, a component of sandalwood oil inhibits migration of breast cancer cells by targeting the beta-catenin pathway. Anticancer Res. 38, 4475–4480 (2018).

Deng, S., Wong, C. K. C., Lai, H. C. & Wong, A. S. T. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/beta-catenin signaling and epithelial-to-mesenchymal transition. Oncotarget 8, 25897–25914 (2017).

Gao, Y. et al. Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the Wnt/beta-catenin signaling pathway. PLoS ONE 9, e85377 (2014).

Lustig, B. & Behrens, J. The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 129, 199–221 (2003).

Kim, J. G. et al. Wnt3A induces GSK-3β phosphorylation and β-catenin accumulation through RhoA/ROCK. J. Cell. Physiol. 232, 1104–1113 (2017).

Rodrigues, P. et al. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. Nat. Commun. 5, 5458 (2014).